Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016 (2016), Article ID 8987928, 9 pages
http://dx.doi.org/10.1155/2016/8987928
Research Article

Nucleolar PARP-1 Expression Is Decreased in Alzheimer’s Disease: Consequences for Epigenetic Regulation of rDNA and Cognition

1Department of Pathology, State University of New York, Downstate Medical Center, Brooklyn, NY 11203, USA
2Department of Neurology, State University of New York, Downstate Medical Center, Brooklyn, NY 11203, USA
3Department of Physics, New York University, New York, NY 10003, USA
4The Robert F. Furchgott Center for Neural and Behavioral Science, State University of New York, Downstate Medical Center, Brooklyn, NY 11203, USA

Received 12 November 2015; Accepted 2 February 2016

Academic Editor: Gerhard Rammes

Copyright © 2016 Jianying Zeng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Masters and K. Beyreuther, “Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Aβ amyloid pathway,” Brain, vol. 129, no. 11, pp. 2823–2839, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Hutton, J. Pérez-Tur, and J. Hardy, “Genetics of Alzheimer's disease,” Essays in Biochemistry, vol. 33, pp. 117–131, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. S. G. Younkin, “The role of Aβ42 in Alzheimer's disease,” Journal of Physiology-Paris, vol. 92, no. 3-4, pp. 289–292, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. S. S. Sisodia, “Alzheimer's disease: perspectives for the new millennium,” The Journal of Clinical Investigation, vol. 104, no. 9, pp. 1169–1170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Masliah, “Mechanisms of synaptic dysfunction in Alzheimer's disease,” Histology and Histopathology, vol. 10, no. 2, pp. 509–519, 1995. View at Google Scholar · View at Scopus
  6. T. J. Montine, C. H. Phelps, T. G. Beach et al., “National institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach,” Acta Neuropathologica, vol. 123, no. 1, pp. 1–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Puzzo, O. Vitolo, F. Trinchese, J. P. Jacob, A. Palmeri, and O. Arancio, “Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity,” Journal of Neuroscience, vol. 25, no. 29, pp. 6887–6897, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Moreno, E. Yu, G. Pigino et al., “Synaptic transmission block by presynaptic injection of oligomeric amyloid beta,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5901–5906, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Cohen-Armon, L. Visochek, A. Katzoff et al., “Long-term memory requires polyADP-ribosylation,” Science, vol. 304, no. 5678, pp. 1820–1822, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. I. Hernández, J. Wolk, J.-Y. Hu et al., “Poly-(ADP-ribose) polymerase-1 is necessary for long-term facilitation in Aplysia,” The Journal of Neuroscience, vol. 29, no. 30, pp. 9553–9562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Goldberg, L. Visochek, E. Giladi, I. Gozes, and M. Cohen-Armon, “PolyADP-ribosylation is required for long-term memory formation in mammals,” Journal of Neurochemistry, vol. 111, no. 1, pp. 72–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. D'Amours, S. Desnoyers, I. D'Silva, and G. G. Poirier, “Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions,” The Biochemical Journal, vol. 342, no. 2, pp. 249–268, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Krishnakumar, M. J. Gamble, K. M. Frizzell, J. G. Berrocal, M. Kininis, and W. L. Kraus, “Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes,” Science, vol. 319, no. 5864, pp. 819–821, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. Á. Fontán-Lozano, I. Suárez-Pereira, A. Horrillo, Y. Del-Pozo-Martín, A. Hmadcha, and Á. M. Carrión, “Histone H1 poly[ADP]-ribosylation regulates the chromatin alterations required for learning consolidation,” The Journal of Neuroscience, vol. 30, no. 40, pp. 13305–13313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. D. Allen, A. V. Gourov, C. Harte et al., “Nucleolar integrity is required for the maintenance of long-term synaptic plasticity,” PLoS ONE, vol. 9, no. 8, Article ID e104364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Guetg and R. Santoro, “Formation of nuclear heterochromatin the nucleolar point of view,” Epigenetics, vol. 7, no. 8, pp. 811–814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. E. K. Boamah, E. Kotova, M. Garabedian, M. Jarnik, and A. V. Tulin, “Poly(ADP-ribose) polymerase 1 (PARP-1) regulates ribosomal biogenesis in Drosophila nucleoli,” PLoS Genetics, vol. 8, no. 1, Article ID e1002442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. T. G. Beach, L. I. Sue, D. G. Walker et al., “The sun health research institute brain donation program: description and experience, 1987–2007,” Cell and Tissue Banking, vol. 9, no. 3, pp. 229–245, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. G. Beach, C. H. Adler, L. I. Sue et al., “Arizona study of aging and neurodegenerative disorders and brain and body donation program,” Neuropathology, vol. 35, no. 4, pp. 354–389, 2015. View at Publisher · View at Google Scholar
  20. S. S. Mirra, A. Heyman, D. McKeel et al., “The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease,” Neurology, vol. 41, no. 4, pp. 479–486, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. B. T. Hyman and J. Q. Trojanowski, “Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 56, no. 10, pp. 1095–1097, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. A. I. Hernández, J. M. Alarcon, and K. D. Allen, “New ribosomes for new memories?” Communicative & Integrative Biology, vol. 8, no. 2, Article ID e1017163, 2015. View at Publisher · View at Google Scholar
  23. A. Kiryk, K. Sowodniok, G. Kreiner et al., “Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons,” Frontiers in Cellular Neuroscience, vol. 7, article 207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Love, R. Barber, and G. K. Wilcock, “Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease,” Brain, vol. 122, no. 2, pp. 247–253, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Parlato, G. Kreiner, G. Erdmann et al., “Activation of an endogenous suicide response after perturbation of rRNA synthesis leads to neurodegeneration in mice,” Journal of Neuroscience, vol. 28, no. 48, pp. 12759–12764, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Cecchi, C. Fiorillo, S. Sorbi et al., “Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients,” Free Radical Biology and Medicine, vol. 33, no. 10, pp. 1372–1379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Adamczyk, H. Jeśko, and R. P. Strosznajder, “Alzheimer's disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus,” Folia Neuropathologica, vol. 43, no. 3, pp. 139–142, 2005. View at Google Scholar · View at Scopus
  28. J. B. Strosznajder, G. A. Czapski, A. Adamczyk, and R. P. Strosznajder, “Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease,” Molecular Neurobiology, vol. 46, no. 1, pp. 78–84, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Iacono, W. R. Markesbery, M. Gross et al., “The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life,” Neurology, vol. 73, no. 9, pp. 665–673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Abel, P. V. Nguyen, M. Barad, T. A. S. Deuel, E. R. Kandel, and R. Bourtchouladze, “Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory,” Cell, vol. 88, no. 5, pp. 615–626, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Lee and H. Ryu, “Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker?” BMB Reports, vol. 43, no. 10, pp. 649–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. J. Day and J. D. Sweatt, “Epigenetic treatments for cognitive impairments,” Neuropsychopharmacology, vol. 37, no. 1, pp. 247–260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Parlato and G. Kreiner, “Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle?” Journal of Molecular Medicine, vol. 91, no. 5, pp. 541–547, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Pietrzak, G. Rempala, P. T. Nelson, J.-J. Zheng, and M. Hetman, “Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease,” PLoS ONE, vol. 6, no. 7, Article ID e22585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Paredes and K. A. Maggert, “Ribosomal DNA contributes to global chromatin regulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 42, pp. 17829–17834, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. Ding, W. R. Markesbery, Q. Chen, F. Li, and J. N. Keller, “Ribosome dysfunction is an early event in Alzheimer's disease,” The Journal of Neuroscience, vol. 25, no. 40, pp. 9171–9175, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Caiafa, T. Guastafierro, and M. Zampieri, “Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns,” The FASEB Journal, vol. 23, no. 3, pp. 672–678, 2009. View at Publisher · View at Google Scholar · View at Scopus